Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents
Feb 6, 2024
12:13
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:
JAMA Author Interviews